InvestSMART

Hydrix Limited (ASX: HYD) - Share Price

- Current share price for HYD : $0.003

Hydrix Limited (HYD) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It provides product design, engineering, and regulatory services to customers in the medical industry, supports market development of cardiovascular technologies, and invests in early-stage medtech clients.

HYD General Information +

ASX Code HYD
Website http://www.hydrix.com
Industry/Sector Electronic Equipment & Instruments
Market Cap ($M) 4
HYD Share Price $0.003
Day High $0.003
Day Low $0.003
Last Close $0.003
HYD Share Price Movement - ( No change )
Prices as at 16:40, 25 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Hydrix Limited (HYD) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Final 1.5¢ 100% 27 Aug 1990 15 Sep 1990 - - -
Interim 1¢ 100% 12 Feb 1990 28 Feb 1990 - - -
Final 1¢ 100% 25 Aug 1989 15 Sep 1989 - - -

See all dividends from Hydrix Limited (HYD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Hydrix Limited (HYD) price-sensitive announcements

HYD - Quarterly Activities/Appendix 4C Cash Flow Report
Hydrix Limited's quarterly cash flow report for the quarter ending June 30, 2026, indicate
Hydrix Limited (HYD)
30 Jul 2026 | 6:14 PM
HYD - Remedy Robotics awards HYD A$3.4M Surgical Robotics Contract
Hydrix Limited (ASX: HYD) announced the securing of a significant A$3.4 million engineerin
Hydrix Limited (HYD)
20 Jul 2026 | 9:29 AM
HYD - Reinstatement of security class- HYDOC
On June 19, 2026, Hydrix Limited's securities were reinstated to quotation under the secur
Hydrix Limited (HYD)
19 Jun 2026 | 8:53 AM
HYD - Results of Retail Entitlement Offer
Hydrix Limited announced the results of its retail entitlement offer, which is a part of a
Hydrix Limited (HYD)
10 Jun 2026 | 2:41 PM

Hydrix Limited (HYD) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Hydrix Medical contract with National Heart Centre Singapore 17 Sep 2026 9:52AM $0.003 $0.003 fallen by 0%
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Hydrix Advancing Strategic Defence Activities 31 Aug 2026 9:13AM $0.004 $0.003 fallen by 14.29%
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Letter from Chairman 28 Aug 2026 2:59PM $0.004 $0.003 fallen by 14.29%
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Preliminary Final Report 28 Aug 2026 2:55PM $0.004 $0.003 fallen by 14.29%
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Hydrix Executive Chair discusses growth strategy on ausbiz 19 Aug 2026 11:17AM $0.003 $0.003 fallen by 0%
Hydrix Limited (HYD)
ORDINARY FULLY PAID
 Information Technology $4 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 6:14PM $0.004 $0.003 fallen by 14.29%

HYD Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$6.72 -$0.50 7.00% 0.00 0.00 0.00% 0.0%
2025A -$3.65 -$0.40 -50.60% 0.00 0.00 0.00% 0.0%
2024A -$7.05 -$0.90 81.30% 0.00 0.00 0.00% 0.0%

HYD Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Codan Limited (CDA) $9,619M 0.6884 0.3424 0.1108 55.0156 40.9818 36.8925 0.92% 1.07% 1.18%
Elsight Limited (ELS) $1,149M -2.2233 0.6667 0.6071 102.3810 61.4286 38.2222 0.00% 0.00% 0.00%
Hydrix Limited (HYD) $4M 0.0698 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

HYD Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -0.54 0.00
Market 0.33 13.80 1.17 0.79
Sector 1.44 45.80 1.52 1.63

HYD Directors

Name Position Start Date
Mr Gavin Coote Executive Chairman, Executive Director 12 Jan 2017
Mr Paul Anthony Lewis Non-Executive Director 28 Oct 2021
Mr Paul Wright Non-Executive Director 8 Aug 2018
Ms Julie King Non-Executive Director 28 Mar 2017

Hydrix Limited (HYD) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
6 Dec 2023 LEWIS, Paul Issued Convertibles 500,000 $1.000 $500,000.000
6 Dec 2023 KING, Julie Issued Convertibles 1,500,000 $1.000 $1,500,000.000
6 Dec 2023 WRIGHT, Paul Issued Convertibles 100,000 $1.000 $100,000.000

See all changes in directors' interest & trades for Hydrix Limited (HYD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

HYD Management

Name Position
Gareth Evan Chief Financial Officer
Alyn Tai Company Secretary

HYD Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Hydrix Limited (HYD). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
30,913,145 (11.33%) John W King Nominees Pty Ltd ATF The King Family Trust
20,423,334 (7.49%) Invia Custodian Pty Ltd
15,667,565 (5.74%) Citicorp Nominees Pty Limited

HYD Calendar of Events

Date Event
27 August 2027 Report (Prelim)
26 February 2027 Report (Interim)
20 October 2026 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.